I help entrepreneurs, startups, and small businesses with grants, business and strategic planning, partnership development, intellectual property, and technology transfer.
We support the success of entrepreneurs and startups developing medical technologies by providing grant and scientific writing services, regulatory approval guidance, and early-stage product development help.
What do you like most about your profession?
I work with other entrepreneurs who share a passion for making a difference. I am always working on something new and interesting. Being focused on the medical space, I have the opportunity to help save lives which makes what I do even more fulfilling.
Describe a recent client engagement or project.
I recently helped a client with a federal grant proposal. It was the first time that this entrepreneur had attempted to write and submit a grant. I described the process to the client and provided a thorough review of all the grant documents prior to submission. My client was awarded the grant and is now able to further build the company.
What are 3 attributes you need to be successful in your industry?
I work with startups developing new medical technologies. To be successful in this field, one needs (1) to have knowledge of the regulatory environment, (2) to be able to manage multidisciplinary teams, and (3) to be patient.
Owner at The Glitch & Co
July 2015 - Present
Our company started in 2015 out of Dallas, Texas. The GLITCH & Co looks at the world through grateful eyes and it is our hope to spread the joy of gratitude well beyond our products. STOP GLITCHIN and be more thankful. Be thankful for food and drinks when others are hungry and thirsty. Be thankful for the gift of shelter, clothing, friends, love and life. Gratitude is a powerful emotion so allow gratitude to take over.
Zintro Expert at Zintro Inc
January 2013 - Present
Owner at Caizio
July 2012 - Present
I work with medtech and biotech startups in the early stages with patenting, licensing, technology transfer, business and strategic planning, investor presentations, proposal writing, and regulatory issues.
President and CEO at Medical Nanotechnologies, Inc.
December 2010 - Present
Director at Heapy Hughes Foundation
September 2009 - Present
Vice President, Science & Technology at Xanapath LLC
January 2009 - January 2010
Senior Research Scientist at Lynntech, Inc.
August 2007 - December 2010
Group Leader, Life Sciences at Zyvex Corporation
June 2003 - July 2007
Director of R&D at Computer Optics Inc.
July 2000 - June 2003
The University of Dallas
Field of Study: Entrepreneurship
University of Minnesota-Twin Cities
Field of Study: Biomedical Engineering
University of Cincinnati
Field of Study: Chemical Engineering
Realizing Complex Microsystems: A Deterministic Parallel Assembly Approach
Publication: NSTI Nanotech 2004 Conference
Date: Dec 10, 2017
The push towards miniaturization has created substantial interest in microelectromechanical systems (MEMS). To date, most of the developments regarding MEMS technology have relied on monolithic fabrication and integration. The monolithic approach has successfully produced various miniature technologies; however, most of these miniature technologies are essentially discrete devices or, at best, simple systems such as pressure sensors and accelerometers. Truly complex systems, by definition, are a combination of independent but interrelated elements that, in totality, function as a unified entity. Computer-controlled, parallel assembly of micromachined components promises to drive the miniaturization wave by enabling the manufacture of unprecedented complex microsystems. Described in this paper is an approach to parallel assembly of microsystems that uses silicon MEMS components, such as grippers and connectors, integrated with high precision robotic systems. Due to the versatility of the deterministic parallel assembly approach described herein, numerous applications of microsystems are realized including fiber optic components, high frequency devices, portable chemical and biological detection systems, and miniature high performance laboratory and industrial instrumentation. In this paper, we discuss the complex microsystems currently being developed using this state-of-the-art assembly process. We also discuss the use of standard micro/nano positioning equipment to achieve automated assembly of these microsystems.
Nanostructure-Mediated Drug Delivery
Date: Mar 01, 2005
Nanotechnology is expected to have an impact on all industries including semiconductors, manufacturing, and biotechnology. Tools that provide the capability to characterize and manipulate materials at the nanoscale level further elucidate nanoscale phenomena and equip researchers and developers with the ability to fabricate novel materials and structures. One of the most promising societal impacts of nanotechnology is in the area of nanomedicine. Personalized health care, rational drug design, and targeted drug delivery are some of the benefits of a nanomedicine-based approach to therapy. This review will focus on the development of nanoscale drug delivery mechanisms. Nanostructured drug carriers allow for the delivery of not only small-molecule drugs but also the delivery of nucleic acids and proteins. Delivery of these molecules to specific areas within the body can be achieved, which will reduce systemic side effects and allow for more efficient use of the drug.